EZH2 and cancer: In this study, the EZH2 inhibitor GSK126 can significantly inhibit the methylation level of histone H3, prevent the proliferation of PC cells in vitro and in vivo, and promote the expressions of apoptosis-related protein to aggravate apoptosis of cancer cells.